GENALAB INC. – Trademark Portfolio

Entity Type: 03

GENALAB INC. holds 3 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 3 (Cosmetics & Cleaning) — 2 filings in this category. The portfolio also extends into Class 5 (Pharmaceuticals) across 2 Nice Classification classes. Currently, 2 trademarks are registered. Notable registered marks include NOTIF. and GENABELLE. The owner is based in Seoul.

2F, 30, Dongmak-ro 2-gil, Mapo-gu

Seoul 04071 , KR

3 Total Trademarks

Add to watchlist:

No watchlists yet
Loading...
By Date
By Name
Filter by Class:

NOTIF
NOTIF
Abandoned 2025
NOTIF.
NOTIF.
Registered 2022
GENABELLE
GENABELLE
Registered 2020

Trademark Classifications

GENALAB INC.'s trademark portfolio spans 2 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.

3
Cosmetics & Cleaning (2 filings)

Bleaching preparations and other substances for laundry use; cleaning, polishing, scouring

5
Pharmaceuticals (1 filing)

Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes

Frequently Asked Questions

How many trademarks does GENALAB INC. have?

GENALAB INC. has 3 U.S. trademarks filed with the USPTO. Of these, 2 registered, 1 abandoned.

What trademark classes does GENALAB INC. file in?

GENALAB INC. files trademarks across 2 Nice Classification classes. The most active classes are Class 3 (Cosmetics & Cleaning), Class 5 (Pharmaceuticals). Class 3 covers bleaching preparations and other substances for laundry use; cleaning, polishing, scouring.

What are GENALAB INC.'s most well-known trademarks?

GENALAB INC.'s registered trademark portfolio includes well-known marks such as NOTIF. and GENABELLE. These are among 2 currently registered trademarks in the portfolio.

What is GENALAB INC.'s trademark registration success rate?

GENALAB INC. has a 67% trademark registration rate, with 2 out of 3 resolved applications resulting in successful registration. Currently, 0 applications are pending review.